The time course and microbiology of surgical site infections after head and neck free flap surgery

Laryngoscope

Volumn 125, Issue 5, 2015, Pages 1084-1089

  Durand, Marlene L ^a   Yarlagadda, Bharat B ^b   Rich, Debbie L ^b   Lin, Derrick T ^b   Emerick, Kevin S ^b   Rocco, James W ^b   Deschler, Daniel G ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

complications; free flap; head and neck cancer; microbiology; reconstructive surgery; Surgical site infection

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ANTEROLATERAL THIGH FLAP; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BENIGN TUMOR; BONE NECROSIS; CANCER SURGERY; FACE MALFORMATION; FIBULA; FOREARM; FREE TISSUE GRAFT; GRAFT FAILURE; GRAFT RECIPIENT; HEAD AND NECK SURGERY; HUMAN; LARYNX TUMOR; LATISSIMUS DORSI FLAP; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOUTH FLORA; PLASTIC SURGERY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCAPULA; SCREENING TEST; SURGICAL INFECTION; SURGICAL PATIENT; ADVERSE EFFECTS; ANTIBIOTIC PROPHYLAXIS; BACTERIUM; FOLLOW UP; HEAD AND NECK NEOPLASMS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL WOUND INFECTION; TIME; UNITED STATES;

ANTIBIOTIC PROPHYLAXIS; BACTERIA; FOLLOW-UP STUDIES; FREE TISSUE FLAPS; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MASSACHUSETTS; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 84928526125     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25038     Document Type: Article

References (40)

1. Karakida K, Aoki T, Ota Y, et al. Analysis of risk factors for surgical site infections in 276 oral cancer surgeries with microvascular free flap reconstructions at a single university hospital. J Infect Chemother 2010; 16: 334-339.
2. Bourget A, Chang JTC, Wu DBS, et al. Free flap reconstruction in the head and neck region following radiotherapy: a cohort study identifying negative outcome predictors. Plast Reconstr Surg 2011; 127: 1901-1908.
3. Lee DH, Kim SY, Nam SY, et al. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol 2011; 47: 528-531.
4. Lotfi CJ, Cavalcanti R, de C, Silva AMC, et al. Risk factors for surgical site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008; 138: 74-80.
5. Ma C-Y, Ji T, Andrew OW, et al. Surgical site infection in elderly oral cancer patients: is the evaluation of comorbid conditions helpful in the identification of high-risk ones. J Oral Maxillofac Surg 2012; 70: 2445-2452.
6. Kamizono K, Sakuraba M, Nagamatsu S, et al. Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol 2014; 21: 1700-1705.
7. Russell MD, Goldberg AN,. What is the evidence for use of prophylactic antibiotics in clean-contaminated head and neck surgery? Laryngoscope 2012; 122: 945-946.
8. Becker GD, Parell GJ, Busch DF, et al. Anaerobic and aerobic bacteriology in head and neck cancer surgery. Arch Otolaryngol 1978; 104: 591-594.
9. Johanson WG, Pierce AK, Sanford JP,. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969; 281: 1137-1140.
10. Johanson WG, Dever LL,. Nosocomial pneumonia. Intensive Care Med 2003; 29: 23-29.
11. Yoshioka H, Fujita K, Maruyama S, et al. Changes in aerobic pharyngeal flora related to antibiotic use and the emergence of gram-negative bacilli. Clin Pediatr (Phila) 1982; 21: 460-462.
12. Watters K, O'Dwyer TP, Rowley H,. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences? J Laryngol Otology 2004; 118: 694-699.
13. Yarlagadda BB, Deschler DG, Rich D, Durand ML,. Low rate of head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Presented at: 5th World Congress, IFHNOS, July 2014; New York, NY. AHNS abstract 58802.
14. Centers for Disease Control and Prevention. Surgical site infection (SSI) Event definitions. Available at: http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Published January 14, 2014. Accessed February 27, 2014.
15. Bratzler DW, Hunt DR,. The Surgical Infection Prevention and Surgical Care Improvement Projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43: 322-330.
16. Pohlenz P, Klatt J, Blessmann M, et al. Microvascular free flaps in head and neck surgery: complications and outcome of 1000 flaps. Int J Oral Maxillofac Surg 2012; 41: 739-743.
17. Suh JD, Sercarz JA, Abemayor E, et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg 2004; 130: 962-966.
18. Bozikov K, Arnez ZM,. Factors predicting free flap complications in head and neck reconstruction. J Plast Reconstr Aesthetic Surg 2006; 59: 737-742.
19. Jones NF, Jarrahy R, Song JI, et al. Postoperative medical complications-not microsurgical complications-negatively influence the morbidity, mortality, and true costs after microsurgical reconstruction for head and neck cancer. Plast Reconstr Surg 2007; 119: 2053-2060.
20. Dassonville O, Poissonnet G, Chamorey E, et al. Head and neck reconstruction with free flaps: a report on 213 cases. Eur Arch Ororhinolaryngol 2008; 265: 85-95.
21. le Nobel GJ, Higgins KM, Enepekides DJ,. Predictors of complications of free flap reconstruction in head and neck surgery: analysis of 304 free flap reconstruction procedures. Laryngoscope 2012; 122: 1014-1019.
22. Benatar MJ, Dassonville O, Chamorey E, et al. Impact of preoperative radiotherapy on head and neck free flap reconstruction: a report on 429 cases. J Plast Reconstr Aesthetic Surg 2013; 66: 478-482.
23. Ogihara H, Takeuchi K, Majima Y,. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx 2009; 36: 457-460.
24. Mucke T, Loeffelbein DJ, Kolk A, et al. Comparison of outcome of microvascular bony head and neck reconstructions using the fibular free flap and the iliac crest flap. Br J Oral Maxillofac Surg 2013; 51: 514-519.
25. Simons JP, Johnson JT, Yu VL, et al. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope 2001; 111: 329-335.
26. Penel N, Fournier C, Lefebvre D, et al. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 2005; 41: 35-44.
27. Yang C-H, Chew K-Y, Solomkin JS, et al. Surgical site infections among high-risk patients in clean-contaminated head and neck reconstructive surgery: concordance with preoperative oral flora. Ann Plast Surg 2013; 71: S55-S60.
28. Wax MK, Rosenthal E,. Etiology of late free flap failures occurring after hospital discharge. Laryngoscope 2007; 117: 1961-1963.
29. Clayman GL, Raad II, Hankins PD, et al. Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 1993; 15: 526-531.
30. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery: the need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992; 118: 1159-1163.
31. Mahesh CB, Ramakant BK, Jagadeesh VS,. The prevalence of inducible and constitutive clindamycin resistance among the nasal isolates of staphylococci. J Clin Diagn Res 2013; 7: 1620-1622.
32. Weber RS, Callender DL,. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol 1992; 101: 16-20.
33. Becker GD, Parell GJ, Busch DF, et al. The non-value of preoperative and intraoperative cultures in predicting the bacteriology of subsequent wound infection in patients undergoing major head and neck cancer surgery. Laryngoscope 1980; 90: 1933-1940.
34. Avery CME, Ameerally P, Castling B, et al. Infection of surgical wounds in the maxillofacial region and free flap donor sites with methicillin-resistant Staphylococcus aureus. Br J Oral Maxillofac Surg 2006; 44: 217-221.
35. Morimoto Y, Sugiura T, Shigeru T, et al. Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer. Spec Care Dentist 2006; 26: 209-213.
36. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopedic surgery. J Bone Joint Surg Am 2010; 92: 1820-1826.
37. Richer SL, Wenig BL,. The efficacy of preoperative screening and the treatment of methicillin-resistant Staphylococcus aureus in an otolaryngology surgical practice. Otolaryngol Head Neck Surg 2009; 140: 29-32.
38. Miyake M, Obbayashi Y, Iwasaki A, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Surg 2007; 65: 2159-2163.
39. Bode LGM, Kluytmans JAJW, Wetheim HFL, et al. Preventing surgical site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9-17.
40. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984; 94: 46-51.